Immunoediting, neoantigen frequency, and clinical outcome in patients with ovarian clear cell carcinoma

被引：1
|
作者：
Hasegawa, K. [1 ]
Matsushita, H. [2 ]
Oda, K. [3 ]
Yamamoto, S. [4 ]
Nishijima, A. [3 ]
Imai, Y. [1 ]
Asada, K. [3 ]
Ikeda, Y. [1 ]
Fujiwara, K. [1 ]
Aburatani, H. [4 ]
Kakimi, K. [2 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[2] Univ Tokyo Hosp, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：7 / 8
页数：3
相关论文
共 50 条
  • [1] Neoantigen frequency as an independent prognostic factor in patients with clear cell ovarian carcinoma (CCOC)
    Matsushita, Hirokazu
    Hasegawa, Kosei
    Oda, Katsutoshi
    Yamamoto, Shogo
    Nishijima, Akira
    Imai, Yuichi
    Asada, Kayo
    Ikeda, Yuji
    Karasaki, Takahiro
    Fujiwara, Keiichi
    Aburatani, Hiroyuki
    Kakimi, Kazuhiro
    CANCER RESEARCH, 2017, 77
  • [2] Postrecurrent Oncologic Outcome of Patients With Ovarian Clear Cell Carcinoma
    Kajiyama, Hiroaki
    Shibata, Kiyosumi
    Mizuno, Mika
    Yamamoto, Eiko
    Fujiwara, Sawako
    Umezu, Tomokazu
    Suzuki, Shiro
    Nakanishi, Toru
    Nagasaka, Tetsuro
    Kikkawa, Fumitaka
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 801 - 806
  • [3] The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
    Shuang Ye
    Shuling Zhou
    Siyuan Zhong
    Boer Shan
    Wenhua Jiang
    Wentao Yang
    Xu Cai
    Huijuan Yang
    BMC Cancer, 22
  • [4] The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
    Ye, Shuang
    Zhou, Shuling
    Zhong, Siyuan
    Shan, Boer
    Jiang, Wenhua
    Yang, Wentao
    Cai, Xu
    Yang, Huijuan
    BMC CANCER, 2022, 22 (01)
  • [5] Clinical features and frequency of mismatch repair protein deficiency in ovarian clear cell and endometrioid carcinoma patients
    Takehara, K.
    ANNALS OF ONCOLOGY, 2019, 30 : 425 - 425
  • [6] Frequency and clinical features of deficient mismatch repair in ovarian clear cell and endometrioid carcinoma
    Tanaka, Tamaki
    Takehara, Kazuhiro
    Yamashita, Natsumi
    Okazawa-Sakai, Mika
    Kuraoka, Kazuya
    Teramoto, Norihiro
    Taguchi, Kenichi
    Yamashiro, Katsushige
    Kato, Hidenori
    Mizunoe, Tomoya
    Suzuki, Rie
    Yamamoto, Dan
    Ueki, Arisa
    Saito, Toshiaki
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 33 (05)
  • [7] CLINICAL AND GENOMIC LANDSCAPE OF OVARIAN CLEAR CELL CARCINOMA
    Cai, Hongbing
    Dai, Mengyuan
    Shi, Yuying
    Ye, Hong
    Wu, Si-Si
    Yuan, Guangwen
    Wu, Lingying
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A134 - A134
  • [8] Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma
    Huang, Huei-Jean
    Yang, Lan-Yan
    Tung, Hsiu-Jung
    Ku, Fei-Chun
    Wu, Ren-Chin
    Tang, Yun-Hsin
    Chang, Wei-Yang
    Jung, Shih-Ming
    Wang, Chun-Chieh
    Lin, Cheng-Tao
    Liu, Feng-Yuan
    Lin, Gigin
    Chen, Min-Yu
    Chou, Hung-Hsueh
    Chang, Ting-Chang
    Chao, Angel
    Lai, Chyong-Huey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (04) : 793 - 804
  • [9] RECURRENCE PATTERN IN PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA
    Yuda, Sayako
    Yunokawa, Mayu
    Shimoi, Tatsunori
    Sasaki, Sayuri
    Koudaira, Makoto
    Yamamoto, Harukaze
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] Clinical Outcome of the Ovarian Clear Cell Carcinoma Compared to other Epithelial Ovarian Cancers when Treated with Paclitaxel and Carboplatin
    Sirichaisutdhikorn, Daranee
    Suprasert, Prapaporn
    Khunamornpong, Surapan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (06) : 1041 - 1045
12345